Does EVEROLIMUS Cause Hepatic encephalopathy? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Hepatic encephalopathy have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.1% of all adverse event reports for EVEROLIMUS.
38
Reports of Hepatic encephalopathy with EVEROLIMUS
0.1%
of all EVEROLIMUS reports
27
Deaths
25
Hospitalizations
How Dangerous Is Hepatic encephalopathy From EVEROLIMUS?
Of the 38 reports, 27 (71.1%) resulted in death, 25 (65.8%) required hospitalization, and 8 (21.1%) were considered life-threatening.
Is Hepatic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
DACLATASVIR (165)
Which EVEROLIMUS Alternatives Have Lower Hepatic encephalopathy Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE